IceCure to Report First Quarter 2025 Financial & Operational Results on May 28, 2025
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Details
News Market Reaction – ICCM
The recorded move for ICCM in the trading session of this news was +0.98%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.

Conference call & webcast info:
Wednesday, May 28, 2025, at 10:00 am EDT
US: 1-888-407-2553
A live webcast will be available at: https://Veidan.activetrail.biz/IcecureQ1-2025
A recording of the webcast will be available at: ir.icecure-medical.com/
About IceCure Medical
IceCure Medical (Nasdaq: ICCM) develops and markets advanced liquid-nitrogen-based cryoablation therapy systems for the destruction of tumors (benign and cancerous) by freezing, with the primary focus areas being breast, kidney, bone and lung cancer. Its minimally invasive technology is a safe and effective alternative to hospital surgical tumor removal that is easily performed in a relatively short procedure. The Company's flagship ProSense® system is marketed and sold worldwide for the indications cleared and approved to date including in the
IR Contact:
Email: investors@icecure-medical.com
Michael Polyviou
Phone: 732-232-6914
Todd Kehrli
Phone: 310-625-4462
Logo - https://mma.prnewswire.com/media/2319310/IceCure_Medical_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/icecure-to-report-first-quarter-2025-financial--operational-results-on-may-28-2025-302461786.html
SOURCE IceCure Medical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.